Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ERGAMISOL

LEVAMISOLE HYDROCHLORIDE

Standard Dose
EQ 50MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview ERGAMISOL is listed in Drugs@FDA under application 020035 (NDA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEVAMISOLE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor JANSSEN PHARMA Submission history Latest submission status date: 1999-12-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview ERGAMISOL is listed in Drugs@FDA under application 020035 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient LEVAMISOLE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 50MG BASE Sponsor JANSSEN PHARMA Submission history Latest submission status date: 1999-12-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.